Skip to content

Medpace Holdings, Inc. MEDP Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Labcorp Holdings logo
Labcorp HoldingsLH
IQVIA logo
IQVIAIQV
Tenet Healthcare logo
Tenet HealthcareTHC
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Guardant Health logo
Guardant HealthGH

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%
Free cash flow$145.0M+25.1%

Valuation

See full
Market cap$13.14B+46.8%
Enterprise value$12.64B+45.9%
P/E28.6×+7.0×
P/S4.9×+0.8×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s common stock, shares authorized (in shares)?
Medpace Holdings, Inc. (MEDP) reported common stock, shares authorized (in shares) of $250M in Q1 2026.
How has Medpace Holdings, Inc.'s common stock, shares authorized (in shares) changed year-over-year?
Medpace Holdings, Inc.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $250M to $250M.
What is the long-term trend for Medpace Holdings, Inc.'s common stock, shares authorized (in shares)?
Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $250M to $250M.